Torii Pharmaceutical Co., Ltd., Tokyo, Japan.
Papermill Medical, Denmark.
Int Immunopharmacol. 2022 Jun;107:108640. doi: 10.1016/j.intimp.2022.108640. Epub 2022 Feb 22.
Der p 23 has recently been recognized as a new house dust mite (HDM) major allergen that may be linked to the development of asthma in HDM allergic patients. This study aimed to investigate the frequency of sensitization to HDM major allergen components including Der p 23 and to examine the correlation between HDM-sensitization and AR symptom score in Japanese HDM allergic rhinitis (AR) patients without allergic asthma. Serum samples (n = 120) collected from Japanese HDM AR patients (12 to 64 years) without asthma were assessed for allergen-specific IgE (s-IgE) by ImmunoCAP (Dermatophagoides pteronyssinus (D. pteronyssinus; Der p) extract, Der p 23) or immunosolid-phase allergen chip (Der p 1, Der p 2). Japanese HDM AR patients without asthma showed a high prevalence of allergic sensitization to the HDM major allergens Der p 1 (94.2%), Der p 2 (97.5%) and Der p 23 (71.7%). No difference in the prevalence was detected for Der p 1 and Der p 2 s-IgE among three age groups. However, the prevalence of Der p 23 s-IgE was significantly higher in the younger group compared to the elderly group. No significant correlation was found between AR symptom scores and concentration of s-IgE towards Der p extract and any of the three HDM major allergens. Although the prevalence of sensitization towards D. pteronyssinus major allergens is high in Japanese AR patients without asthma, there was no correlation between allergen specific IgE including IgE towards Der p 23 and AR symptom in this population.
Der p 23 最近被认为是一种新的屋尘螨 (HDM) 主要过敏原,可能与 HDM 过敏患者哮喘的发展有关。本研究旨在调查日本 HDM 过敏性鼻炎 (AR) 患者中 HDM 主要过敏原成分(包括 Der p 23)致敏的频率,并研究 HDM 致敏与 AR 症状评分之间的相关性,这些患者无哮喘。通过 ImmunoCAP(屋尘螨(D. pteronyssinus;Der p)提取物、Der p 23)或免疫固相过敏原芯片(Der p 1、Der p 2)评估了 120 例来自日本无哮喘 HDM AR 患者(12 至 64 岁)的血清样本中过敏原特异性 IgE(s-IgE)。日本无哮喘 HDM AR 患者对 HDM 主要过敏原 Der p 1(94.2%)、Der p 2(97.5%)和 Der p 23(71.7%)表现出高过敏致敏率。三个年龄组中,Der p 1 和 Der p 2 s-IgE 的流行率没有差异。然而,年轻组中 Der p 23 s-IgE 的流行率明显高于老年组。AR 症状评分与 Der p 提取物和三种 HDM 主要过敏原中的任何一种的 s-IgE 浓度之间没有显著相关性。尽管日本无哮喘 AR 患者对屋尘螨主要过敏原的致敏率较高,但在该人群中,Der p 23 特异性 IgE 与 AR 症状之间没有相关性。